HIK.L - Hikma Pharmaceuticals PLC

LSE - LSE Delayed Price. Currency in GBp
1,691.00
-16.00 (-0.94%)
As of 4:35PM BST. Market open.
Stock chart is not supported by your current browser
Previous Close1,707.00
Open1,712.50
Bid1,685.00 x 16300
Ask1,687.00 x 34600
Day's Range1,652.00 - 1,712.50
52 Week Range1,290.00 - 2,089.00
Volume696,889
Avg. Volume697,249
Market Cap4.092B
Beta (3Y Monthly)0.48
PE Ratio (TTM)14.52
EPS (TTM)116.50
Earnings DateAug 9, 2019
Forward Dividend & Yield0.40 (2.27%)
Ex-Dividend Date2019-04-04
1y Target Est23.92
  • Calculating The Fair Value Of Hikma Pharmaceuticals PLC (LON:HIK)
    Simply Wall St.14 days ago

    Calculating The Fair Value Of Hikma Pharmaceuticals PLC (LON:HIK)

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we will run through one way of estimating the intrinsic value of Hikma Pharmaceuticals PLC (LON...

  • PR Newswire19 days ago

    Hikma Sponsors MIT Grand Hack to Support Global Healthcare Innovation

    The Grand Hack is MIT Hacking Medicine's annual flagship event dedicated to energise, infect and teach healthcare entrepreneurship and digital strategies to scale medicine as a way to solve health problems worldwide.  More than 500 participants, mentors and sponsors from 25 US states and 29 countries are expected to gather on campus in the MIT Media Lab for this year's Grand Hack, the largest healthcare hackathon in the US. As a strategic sponsor, Hikma and its venture capital arm Hikma Ventures will support the Grand Hack's 'Personalised Medicine' theme, which focuses on solving challenges in improving preventative medicine, treatment affordability and personalised medicine dosages.  Hikma will also have representatives on-site to speak with those attendees interested in exploring opportunities to join Hikma in its mission of putting better health within reach of millions of people through its high-quality medicines and healthcare solutions.

  • PR Newswire20 days ago

    Hikma launches 100th injectable medicine in US with introduction of Vancomycin Hydrochloride for Injection, USP

    "Vancomycin Hydrochloride for Injection is an essential antibiotic used by hospitals to treat patients who have failed to respond to a number of other antibiotics, and it's another important addition to our growing US portfolio," said Dan Motto, Executive Vice President, Commercial and Development, Injectables.

  • Drug companies that benefit from the war on opioid addiction
    Yahoo Finance2 months ago

    Drug companies that benefit from the war on opioid addiction

    The opioid crisis in the United States is a medical and societal tragedy, but some companies are working to fight addiction.

  • FTSE 100 in seventh heaven as oil, miners gain; Ocado hits life high
    Reuters2 months ago

    FTSE 100 in seventh heaven as oil, miners gain; Ocado hits life high

    The FTSE 100 was up 0.3 percent. The domestically-focused FTSE 250 was up 0.3 percent as investors waited for further Brexit developments with reports that Prime Minister Theresa May would ask the European Union to delay Brexit by at least three months. May's Brexit plans were derailed after the speaker of Britain's parliament said on Monday that her deal could not be voted on again after two thumping defeats unless a different proposal was submitted.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of HIK.L earnings conference call or presentation 13-Mar-19 9:30am GMT

    Full Year 2018 Hikma Pharmaceuticals PLC Earnings Call

  • Hikma Pharmaceuticals PLC (LON:HIK): What’s The Analyst Consensus Outlook?
    Simply Wall St.2 months ago

    Hikma Pharmaceuticals PLC (LON:HIK): What’s The Analyst Consensus Outlook?

    In December 2018, Hikma Pharmaceuticals PLC (LON:HIK) announced its latest earnings update, which showed that the company turned profitable again after experiencing negative earnings in the previous financial year. Below,Read More...

  • Reuters2 months ago

    Hopes Britain will reject no-deal Brexit buoy Europe, Inditex slides

    European shares jumped on Wednesday as investors bet British lawmakers would vote to reject a disorderly no-deal Brexit, but underwhelming results from Inditex and Adidas kept gains limited. Lawmakers resoundingly voted against Prime Minister Theresa May's amended Brexit deal late on Tuesday, forcing parliament to decide whether to back a no-deal Brexit or seek a last-minute delay to the process. "I think the market can see that today parliament is going to vote against no deal," said Duncan Weldon, cross asset allocation strategist at Legal & General Investment.

  • Reuters2 months ago

    Hikma guides for injectables growth after profit surge

    (Reuters) - Hikma Pharmaceuticals Plc on Wednesday forecast growth in 2019 for its injectable drugs division, as strong demand along with a rebound in its generics business helped it post a 19 percent ...

  • What Investors Should Know About Hikma Pharmaceuticals PLC’s (LON:HIK) Financial Strength
    Simply Wall St.3 months ago

    What Investors Should Know About Hikma Pharmaceuticals PLC’s (LON:HIK) Financial Strength

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Small and large cap stocks are widelyRead More...

  • Simply Wall St.5 months ago

    Read This Before Buying Hikma Pharmaceuticals PLC (LON:HIK) Shares

    We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders Read More...

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of HIK.L earnings conference call or presentation 15-Aug-18 8:30am GMT

    Half Year 2018 Hikma Pharmaceuticals PLC Earnings Call

  • Business Wire6 months ago

    Hikma Demonstrates Support for US Pharmacists and Patient Safety

    Activities at upcoming ASHP conference include sponsorship of important symposium advancing patient safety practices

  • Reuters6 months ago

    Royal Mail seen dropping out of top British stock index

    Postal company Royal Mail (RMG.L) is set to lose its place in the FTSE 100 (.FTSE), while insurer Hiscox (HSX.L) is likely to join Britain's top stock index in a reshuffle next week, analysts said. Demotion from the blue-chip index would come just as Royal Mail heads into its busiest time of year, as Britons send millions of greeting cards to family and friends in the run-up to Christmas. The possible swap comes after Royal Mail unveiled a broad review of its operations as it battles to cut costs after reporting a 25 percent drop in half-year profit.

  • Theravance's Respiratory Disease JAK Inhibitor Enters Phase I
    Zacks6 months ago

    Theravance's Respiratory Disease JAK Inhibitor Enters Phase I

    Theravance (TBPH) doses the first patient in a phase I study on novel JAK inhibitor, TD-8236, for treating serious respiratory diseases.

  • Theravance JAK Inhibitor Enters Phase II for Crohn's Disease
    Zacks6 months ago

    Theravance JAK Inhibitor Enters Phase II for Crohn's Disease

    Theravance (TBPH) doses the first patient in a phase II Crohn's disease study on JAK inhibitor, TD-1473.

  • U.K. Economy Grows at Fastest Pace in Nearly a Year: 5 Picks
    Zacks8 months ago

    U.K. Economy Grows at Fastest Pace in Nearly a Year: 5 Picks

    The football World Cup and unexpectedly warm weather led to a pickup in consumer spending.